This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Granules India, the Delhi HC recorded a settlement after Granules’ undertaking for exemption under Section 107A a.k.a However, the provision which is an exception to patentinfringement is often criticised for its broad scope. We are very excited to announce the SpicyIP Tech Innovation Policy Fellowship 2025!
Over to Ian : "In European Patent Office (EPO) opposition proceedings, a company accused of patentinfringement has the right to intervene. The Enlarged Board has accepted the case as G 2/24 and invited stakeholders and the President of the EPO to provide comments by 17 April 2025.
announced it has signed a settlement agreement with Bayer Inc. The settlement resolves multiple patentinfringement proceedings in the Federal Court of Canada. Under the agreement, Biocon can launch YESAFILI in Canada no later than July 1, 2025. On March 4, Biocon Biologics Ltd. and Regeneron Pharmaceuticals, Inc.
Background The Petitioner, InterDigital (“ID”), initiated patentinfringement proceedings against Oppo, One Plus and Redme (“defendants”) concerning 8 standard essential patents. These patents concern wireless communication technology standards (IN 262910, 295912, 313036, 319673, 320182) and H.265
by Dennis Crouch For the vast majority of American history, a judgment of patentinfringement (by a court sitting in equity) led almost directly to injunctive relief barring ongoing infringement. Adam Mossoff, Injunctions for PatentInfringement: Historical Equity Practice Between 1790 – 1882 , Harvard J.
Lodha TM battle Following disagreements over how a family settlement agreement is to be interpreted, the Lodha brothers are tangling over the Lodha trademark. Union Budget 2025-26: Whats in it for Innovation, Tech, Trade and Health? The FM Nirmala Sitharaman on February 1 presented the Union Budget 2025-26. amongst others.
We organize all of the trending information in your field so you don't have to. Join 9,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content